The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia
The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia is a paper indexed in ScholarIQ from OpenAlex.
How many citations does The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia have?
The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia has 15 citations in the OpenAlex counts ScholarIQ stores.
When was The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia published?
The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia has 2022 year in the ScholarIQ index.
What is the open-access status of The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia?
The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia has hybrid oa status in the ScholarIQ index.
What is the DOI of The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia?
The DOI for The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia is on the source record.
What is the PMID of The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia?
The PMID for The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia is on the source record.
What is the OpenAlex record for The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia?
The OpenAlex for The negative impact of vitamin D on antipsychotic drug exposure may counteract its potential benefits in schizophrenia is on the source record.